China National Accord Medicines Corporation Ltd. (SHE:000028)

China · Delayed Price · Currency is CNY

19.66

+0.29 (1.50%)

Sep 30, 2026, 3:04 PM CST

Market Cap	11.30B -13.1%
Revenue (ttm)	72.89B -0.7%
Net Income	1.08B +90.5%
EPS	1.75 +91.0%
Shares Out	612.22M
PE Ratio	11.20
Forward PE	10.46
Dividend	0.56 (2.85%)
Ex-Dividend Date	Jun 24, 2026

Volume	1,736,751
Open	19.72
Previous Close	19.37
Day's Range	19.35 - 19.72
52-Week Range	18.70 - 24.94
Beta	0.10
Analysts	Buy
Price Target	24.21 (+23.14%)
Earnings Date	Oct 27, 2026

About SHE:000028

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and health products. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. China National Accord Medicines Corporation Ltd. was incorporat... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1993

Employees 39,449

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000028

Full Company Profile

Financial Performance

In 2025, SHE:000028's revenue was 73.42 billion, a decrease of -1.29% compared to the previous year's 74.38 billion. Earnings were 1.14 billion, an increase of 76.80%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 000028 stock is "Buy." The 12-month stock price target is ¥24.21, which is an increase of 23.14% from the latest price.

Price Target

¥24.21

(23.14% upside)

Analyst Consensus: Buy

Stock Forecasts